Pioglitazone stabilizes atherosclerotic plaque by regulating the Th17/Treg balance in AMPK-dependent mechanisms

Tian, YL; Chen, T; Wu, Y; Yang, L; Wang, LJ; Fan, XJ; Zhang, W; Feng, JH; Yu, H; Yang, YJ; Zhou, J; Yuan, ZY; Wu, Y

Yuan, ZY; Wu, Y (reprint author), Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Cardiol, 277 West Yanta Rd, Xian 710061, Shaanxi, Peoples R China.

CARDIOVASCULAR DIABETOLOGY, 2017; 16 ( ):

Abstract

Background: Pioglitazone (PIO), a thiazolidinediones drug, is a well-known anti-diabetic medicine, but its anti-atherosclerotic effects remain controv......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索